Salvage Liver Transplantation: A Second Chance for Liver Cancer Patients

Salvage Liver Transplantation: A Second Chance for Liver Cancer Patients

Jordan Keane monogram
Jordan Keane in Health & Wellness November 2026 • 4 min read.

"Unlocking the Potential of SLT Strategy for Resectable Hepatocellular Carcinoma (HCC)"


Salvage Liver Transplantation (SLT) is a strategy developed for patients with initially resectable and transplantable hepatocellular carcinoma (HCC). SLT aims to conserve the donor pool and identify patients who benefit from resection. Resection involves surgically removing a portion of the liver containing cancerous tissue.

The primary goal of a study featured in Hepatology (2018) was to evaluate the curative potential of SLT and identify factors predictive of success. Researchers sought to determine how effective SLT is in providing long-term benefits and which patients are most likely to experience positive outcomes.

This article delves into the SLT strategy, exploring its criteria, effectiveness, and the factors that contribute to successful outcomes. By understanding the benefits and limitations of SLT, healthcare professionals and patients can make informed decisions about treatment options for HCC.

AI Search Multiple angles on this topic

Current Impact

Salvage liver transplantation offers a potential second treatment pathway for selected patients with hepatocellular carcinoma (HCC) whose disease returns after earlier treatment. Its impact depends on recurrence, liver function, tumor progression, and access to transplantation. Because no subsection-specific sources were provided, the scale of its current use and outcomes should be interpreted cautiously.

Treatment Approach

Management of HCC may involve liver resection, transplantation, or other curative and local treatments, depending on the patient's disease and liver condition. Salvage transplantation is considered after recurrence or deterioration when earlier treatment is no longer sufficient. Without subsection-specific sources, the comparative benefits and limitations of these approaches cannot be stated precisely.

Origins of Salvage Transplantation

The strategy of salvage liver transplantation originated for patients with initially resectable and transplantable HCC, allowing liver resection first and transplantation if the cancer recurred. It was proposed in part because organ shortages made upfront transplantation difficult and increased the risk that patients would leave the waiting list as tumors progressed. By 2007, programs had described liver resection as the primary treatment followed by salvage transplantation in cases of HCC recurrence or liver failure.

What is Salvage Liver Transplantation (SLT) and How Does It Work?

Salvage Liver Transplantation: A Second Chance for Liver Cancer Patients

SLT is a strategy that focuses on patients with resectable and transplantable HCC. This approach centers around performing an initial resection of the liver to remove cancerous tissue, with the intention of subsequent transplantation if the cancer recurs within the Milan criteria. The Milan criteria are a set of guidelines used to assess the suitability of liver transplant candidates with HCC.

The SLT strategy aims to:

  • Conserve the donor pool by avoiding liver transplants in patients who may not need them if the initial resection is successful.
  • Prevent patients from dropping off the transplant waitlist due to tumor progression while waiting for a donor organ.
  • Avoid pre-emptive OLTX (Orthotopic Liver Transplantation) after resection based solely on the histopathological findings of the resected specimen.
  • Exclude resection as a bridging therapy to OLTX after listing and postoperative liver failure following resection.
AI Search Multiple angles on this topic

Current Evidence

Recent research on salvage liver transplantation continues to examine its role for recurrent HCC and how it should be selected among available treatments. Reviews and comparative studies may help clarify which patients benefit most, but conclusions depend on the populations and treatment strategies examined. Because no subsection-specific sources were supplied, no particular recent result or numerical estimate can be attributed here.

Limitations and Risks

Salvage liver transplantation is not universally successful and may involve substantial clinical and logistical limitations. Recurrence, progression while awaiting transplantation, and the risks of major surgery can affect whether the strategy achieves its intended benefit. The absence of subsection-specific sources means that particular failure rates or risk estimates should not be inferred.

Salvage Versus Alternatives

A 2024 systematic review and meta-analysis reported that salvage liver transplantation provided significant long-term survival advantages over local curative treatments for patients with recurrent HCC. Other research has directly compared primary liver transplantation (PLT) with salvage liver transplantation (SLT) to assess oncological outcomes. A separate retrospective study compared salvage living donor liver transplantation with repeat liver resection, examining survival outcomes and recurrence patterns.

For patients to be considered suitable for resection within the SLT strategy, specific criteria must be met. These include the absence of prohibitive comorbidities, acceptable liver function, the feasibility of RO-resection (R0 resection, meaning complete removal of the tumor with no remaining cancer cells at the margins), and the absence of extrahepatic tumor manifestation (spread of cancer outside the liver).

Key Indicators for Successful SLT Outcomes

Between 1994 and 2012, a study was conducted involving 356 patients with cirrhosis and HCC who underwent liver resection. Out of these patients, 246 did not meet the criteria for OLTX at the time of resection. The study population consisted of 110 patients, with 63 (57%) experiencing HCC recurrence after the initial operation. SLT was performed in 30 patients. The SLT strategy was successful in 60 patients (56%), either through resection alone (36%) or OLTX after HCC recurrence (19%).

AI Search Multiple angles on this topic

Evidence in Context

A systematic review describes salvage liver transplantation as a treatment strategy for recurrent HCC and compares it with curative locoregional therapy. The available evidence also characterizes SLT as controversial, with compromised survival outcomes and increased perioperative morbidity reported in comparison with primary liver transplantation. These findings support a careful, patient-specific interpretation rather than treating salvage transplantation as an automatic replacement for initial transplantation.

Future Directions

Future progress in salvage liver transplantation will likely depend on better selection of patients whose recurrent HCC remains suitable for transplantation. Research may also clarify how salvage transplantation should be positioned against repeat resection and other curative treatments. Because no subsection-specific sources were provided, specific future technologies, timelines, or projected outcomes cannot be stated reliably.

Organ Shortage and Access

Organ shortage is a central reason salvage liver transplantation has been proposed for patients who first undergo liver resection for HCC. The strategy can also be considered after HCC recurrence or deterioration of liver function, rather than requiring transplantation at the initial diagnosis. Sources further note that limited donor availability can increase the risk of tumor progression and dropout from the transplant waiting list.

Patient-Centered Decisions

For patients with recurrent HCC, salvage liver transplantation can represent a further potential curative option after earlier treatment. Whether it is appropriate depends on the individual's recurrence, liver function, surgical risks, and access to a donor organ. Without subsection-specific sources, the effects on quality of life, caregiving, and patients' personal experiences cannot be described in detail.

Predictive factors for a successful SLT strategy included a MELD score > 10 (Model for End-Stage Liver Disease, a scoring system to assess the severity of chronic liver disease) and the absence of TACE (transarterial chemoembolization, a locoregional therapy for liver cancer). After resection, the absence of post-resection morbidity and a T1-2 stage were predictive factors.

The SLT strategy is curative only in 56% of cases. A higher MELD score at the start of the strategy and no prior TACE before resection are predictive factors for a successful SLT strategy. SLT offers a valuable treatment option for select patients with HCC, with the potential for long-term survival and improved quality of life.

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What exactly is Salvage Liver Transplantation (SLT), and why is it considered a viable option for liver cancer patients?

Salvage Liver Transplantation (SLT) is a strategy for individuals with resectable Hepatocellular Carcinoma (HCC) who may need a liver transplant if the cancer recurs. The initial step involves a resection of the liver to remove cancerous tissue. If the cancer returns but still meets the Milan criteria, a liver transplant is considered. SLT aims to conserve the donor pool and ensure that patients who genuinely benefit from a transplant receive one, and to avoid patients dropping off the transplant waitlist due to tumor progression. This contrasts with pre-emptive Orthotopic Liver Transplantation (OLTX) after resection, based only on the histopathological findings.

2

In the context of Salvage Liver Transplantation (SLT), what are the Milan criteria, and why are they important?

The Milan criteria are crucial guidelines used to determine if a patient with Hepatocellular Carcinoma (HCC) is a suitable candidate for a liver transplant. They help assess the extent and characteristics of the tumor to predict the likelihood of successful transplantation. These guidelines help prevent patients from dropping off the waitlist, and to avoid pre-emptive OLTX (Orthotopic Liver Transplantation). While not explicitly mentioned, other important factors include the patient's overall health, liver function, and the absence of other significant medical conditions that could impact the success of the transplant.

3

What are the key indicators that suggest a patient will have a successful outcome with Salvage Liver Transplantation (SLT)?

Key indicators include the absence of prohibitive comorbidities, acceptable liver function, the feasibility of RO-resection (complete removal of the tumor with no remaining cancer cells at the margins), and the absence of extrahepatic tumor manifestation (spread of cancer outside the liver). These criteria ensure that patients undergoing Salvage Liver Transplantation (SLT) have the best chance of a successful outcome, avoiding potential complications from pre-emptive Orthotopic Liver Transplantation (OLTX). Success is measured by recurrence-free survival and overall survival rates after the initial resection and subsequent transplant, if needed.

4

Can you summarize the findings of the study conducted between 1994 and 2012, and how do those results reflect the success of the Salvage Liver Transplantation (SLT) strategy?

The study between 1994 and 2012 showed that out of 356 patients with cirrhosis and HCC who underwent liver resection, a subset of 110 patients met specific criteria. Among these, 63 (57%) experienced HCC recurrence, and 30 of them underwent Salvage Liver Transplantation (SLT). Ultimately, the SLT strategy proved successful in 60 patients (56%), either through resection alone (36%) or Orthotopic Liver Transplantation (OLTX) after HCC recurrence (19%). This highlights that, more than half of the patient population in the study did well via resection alone.

5

What role does resection play in the Salvage Liver Transplantation (SLT) strategy, and how does it contribute to the overall treatment plan?

Resection involves the surgical removal of a portion of the liver containing cancerous tissue, and it's the initial step in the Salvage Liver Transplantation (SLT) strategy for resectable Hepatocellular Carcinoma (HCC). The goal of resection is to remove the primary tumor, and determine if a liver transplant is required later. Complete RO-resection with no remaining cancer cells is key. If the cancer recurs, Orthotopic Liver Transplantation (OLTX) may be considered. It is important to have resection alone as an option as more than one third of the study's patient population was successful with this method alone.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.